Clinical Gallery
Transforming CT
Aquilion ONE / GENESIS Edition goes beyond the evolution of dynamic volume CT. Intensive clinically focused research and breakthrough technological developments have culminated in a CT system with industry-leading spatial resolution and reduced radiation dose requirements.
Advanced intelligent Clear-IQ Engine (AiCE) is now available on Aquilion ONE / GENESIS Edition.
Advanced intelligent Clear-IQ Engine (AiCE) is now available on Aquilion ONE / GENESIS Edition.
FIRST, Thoracic CT
Aquilion ONE GENESIS
A Thoracic CT without contrast was performed on an 8-year-old boy. Multiplanar Reconstruction and fused 3D Volume Rendered images demonstrate nodular like consolidation areas in the upper right lung and other consolidations bilaterally in the lower lobes.
*AAPM Report 96, k-factor 0.015
| Scan Mode | Ultra-Helical |
| Collimation | 0.5 mm x 80 |
| kVp | 100 |
| mAs | SURE Exposure |
| Rotation Time | 0.3 s |
| Scan Range | 202.5 mm |
| Dose Reduction | FIRST |
| CTDIvol | 1.9 mGy |
| DLP | 48.6 mGy•cm |
| Effective Dose* | 0.016 mSv |
FIRST, Coarctation of the Aorta
Aquilion ONE GENESIS
3-month-old baby, ONE rotation volumetric CT scan was performed to visualise the patient's vascular anatomy. FIRST, Forward projected model-based Iterative Reconstruction SoluTion, was implemented into the protocol and automatically applied to the scan. 3D Volume Rendered and Multiplanar Reconstruction (MPR) demonstrate a coarctation of the aorta.
*AAPM Report 96, k-factor 0.039
| Scan Mode | Volume |
| Collimation | 0.5 mm x 160 |
| kVp | 80 |
| mAs | 26 |
| Rotation Time | 0.275 s |
| Scan Range | 80 mm |
| Dose Reduction | FIRST |
| CTDIvol | 0.7 mGy |
| DLP | 5.8 mGy•cm |
| Effective Dose* | 0.22 mSv |
Due to medical device regulatory reasons, not all products/service displayed on this Canon Medical Systems ANZ webpage are available in all countries, regions or markets. Future availability of the products/service cannot also be guaranteed. Please contact your local Canon Medical Systems representative for further details.
